Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Nov 10, 2026 · Filed Nov 12, 2026
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider buying
First insider buy since Sep 2025Traded Nov 10 · filed 2 days later
A major shareholder of Biodesix paid $1M out of pocket for Biodesix shares. It was the first purchase in over a year. Shares held went up 18% with this purchase.
Insider filing
Traded Sep 30 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Sep 30 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
